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Abstract: Genetic variations in ephrin type-A receptor 2 (EPHA2) have been associated with inherited
and age-related forms of cataract in humans. Here, we have characterized the eye lens phenotype
and transcript profile of germline Epha2 knock-in mutant mice homozygous for either a missense
variant associated with age-related cataract in humans (Epha2-Q722) or a novel insertion-deletion
mutation (Epha2-indel722) that were both located within the tyrosine-kinase domain of EPHA2.
Confocal imaging of ex vivo lenses from Epha2-indel722 mice on a fluorescent reporter background
revealed misalignment of epithelial-to-fiber cell meridional-rows at the lens equator and severe
disturbance of Y-suture formation at the lens poles, whereas Epha2-Q722 lenses displayed mild
disturbance of posterior sutures. Immunofluorescent labeling showed that EPHA2 was localized
to radial columns of hexagonal fiber cell membranes in Epha2-Q722 lenses, whereas Epha2-indel722
lenses displayed disorganized radial cell columns and cytoplasmic retention of EPHA2. Immunoprecipitation/blotting studies indicated that EPHA2 formed strong complexes with Src kinase and was
mostly serine phosphorylated in the lens. RNA sequencing analysis revealed differential expression
of several cytoskeleton-associated genes in Epha2-mutant and Epha2-null lenses including shared
downregulation of Lgsn and Clic5. Collectively, our data suggest that mutations within the tyrosinekinase domain of EPHA2 result in lens cell patterning defects and dysregulated expression of several
cytoskeleton-associated proteins.
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1. Introduction
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First identified as epithelial cell kinase (eck), ephrin type-A receptor 2 (EPHA2) belongs to the largest subfamily of receptor tyrosine kinases that were originally discovered in
a human erythropoietin-producing-hepatoma (EPH) cell line [1,2]. EPH receptors and their
membrane-bound EPH receptor interacting ligands, or ephrins, play key signaling roles
in embryonic development including tissue patterning, neurogenesis and vasculogenesis,
adult tissue physiology including bone homeostasis and insulin secretion along with various diseases including cancers and neurodegeneration [3–5]. The mammalian EPH/ephrin
receptor subfamily comprises 14 receptors divided into type-A (EPHA1-8, 10) and type-B
(EPHB1-5) that preferentially interact with ephrin type-A (EFNA1-5) and type-B (EFNB1-3)
ligands, respectively, to elicit forward (receptor-driven) or reverse (ligand-driven) bidirectional signaling in neighboring cells. Like other receptor tyrosine kinases, EPHA2 shares
a type-1 (single-pass) transmembrane glycoprotein topology with several functional domains including an extracellular (N-terminal) ligand binding domain and an intracellular
(C-terminal) tyrosine kinase (TK) signaling domain and a sterile-alpha-motif (SAM) domain implicated in modulating kinase activity and receptor dimerization [6,7]. Canonical
forward signaling by EFNA1-EPHA2 often promotes cell–cell repulsion accompanied by
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EPHA2 oligomerization, phosphorylation, and kinase activation, whereas EPHA2-EFNA1
reverse signaling elicits kinase-independent cell–cell adhesion or repulsion depending
on the specific cellular–extracellular context [8,9]. In addition, EPHA2 possesses ligandindependent kinase activity in many cultured tumor cell types [8,10] and overexpression of
EPHA2 serves both as a prognostic marker and therapeutic target in various human epithelial cancers (e.g., breast, gastric, and lung), glioblastoma, and melanoma, whereas EPHA2
sequence variants have been associated with susceptibility to Kaposi’s sarcoma [9,11,12].
In addition, EPHA2 serves as a receptor for the growth factor progranulin [13] and several
infectious agents including oncogenic viruses and fungal pathogens, and is involved in
blood–brain barrier breakdown during malarial infection [14–16].
Besides cancer and infectious diseases, EPHA2 has been repeatedly linked with clouding of the eye lens or cataract(s)—a leading cause of visual impairment worldwide [17].
Currently, at least 23 coding, mutations in the human EPHA2 gene (EPHA2) underlie
inherited, mostly autosomal dominant, forms of early-onset cataract often with a variable clinical morphology described as nuclear, cortical, and posterior polar/sub-capsular
opacities depending on their location within the lens [18] (https://cat--map.wustl.edu/; accessed on 30 July 2021). Most EPHA2 mutations underlying inherited cataract are missense
or frameshift with the majority located in cytoplasmic regions of the receptor including
the SAM and TK domains. In addition to relatively rare forms of inherited cataract, at
least 12 common single nucleotide variants in EPHA2 (mostly non-coding) including one
non-synonymous coding variant (p.R721Q) located in the TK domain have been associated
with susceptibility to the much more prevalent forms of age-related nuclear, cortical, and
posterior sub-capsular cataracts [19,20] (https://cat--map.wustl.edu/; accessed on 30 July
2021). Further, in addition to such germline cataract-risk variants, EPHA2 coding variants
predicted to be functionally deleterious have been found in genomic DNA from lenses of
adults over 50 years of age raising the possibility that somatic EPHA2 variants may also
contribute to the risk for age-related cataract [21].
The crystalline lens is a transparent, ellipsoidal, biomechanical structure that plays
a critical role in anterior eye development and variable fine-focusing of images onto the
photosensitive retina [22,23]. At the cellular level, the lens is surrounded by a basement
membrane or capsule containing an anterior monolayer of epithelial cells that divide
and terminally differentiate throughout life into highly elongated fiber cells precisely
organized into tightly packed, concentric layers or growth shells to form the refractive mass
(nucleus and cortex) of the lens [24,25]. Lens fiber cell differentiation is characterized by
cytoplasmic accumulation of crystallin proteins, plasma membrane specialization including
gap-junction plaques, actin cytoskeleton remodeling, programmed organelle loss, and
core syncytium formation [24,26–29]. EPHA2 is an abundant component in the lens cellmembrane proteome accounting for ~10% of cell signaling molecules [30]. Disruption of
the mouse EPHA2 gene (Epha2) has been associated with a variable lens phenotype ranging
from severe progressive cataract formation and lens rupture to subtle nuclear opacities
or clear lenses with translucent regions resulting from lens cell disorganization [20,31–36].
Here, we characterize the lens phenotype and gene expression profile of the first mice, to
our knowledge, harboring mutations in the TK domain of EPHA2.
2. Materials and Methods
2.1. Mice and Lenses
Epha2-null mice (Stock no. 006028) [37], transgenic tandem-dimer (td)-Tomato (tdT)
reporter mice (Stock no. 007576) [38], and C57BL/6J (B6J) mice (Stock no. 000664) were
obtained from The Jackson Laboratory (Bar Harbor, ME, USA). Germline Epha2-mutant
mice were generated by clustered regularly interspersed short palindromic repeats and
CRISPR-associated protein 9 (CRISPR/Cas9) gene editing technology in our Genome
Engineering and iPSC Center (GEiC) and Mouse Embryo Stem (ES) Cell Core facility using
standard protocols as described [39]. Briefly, guide RNAs (gRNAs) were designed in
silico flanking the target site and selected based on minimum off-target sites and distance
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from target site. A donor single-stranded oligo-deoxynucleotide (ssODN) was designed
to introduce a non-synonymous (p.R722Q) variant into exon-13 of Epha2 to replicate that
(p.R721Q) predicted to be associated with age-related cortical cataract in humans [20].
Sequences of the gRNAs and ssODN were as follows:
Epha2.g2, 50 -gttcagtgtacttcagttggngg; Epha2.g3, 50 -ttcagtgtacttcagttggtngg; Epha2.ssODNantisense, 50 -ggc cag gtc ccg gtg cac gta gtt cat gtt ggc cag gta ctt cat gcc gga tgc gat acc ctg
cag cat gcc cac tag ctg aag tac act gaa ctc acc atc ctt ctc ctg cag aga tag gcc ctc agt gct gac cgg.
Correctly edited and ‘off-target’ founder mice were identified by PCR-amplification and
Sanger sequencing with gene-specific primers (Table S1, Figure S1) as described [39] and
subsequently bred onto the B6J genetic background to avoid a deletion mutation in the gene
for lens beaded-filament-structural-protein-2 (CP49) carried by some inbred strains [40].
Epha2-null mice (B6J background) were genotyped by PCR-amplification as described [34].
Epha2-mutant mice were crossed with tdT-reporter mice (B6J background) to generate
mutant and wild type littermates that constitutively express membrane-targeted tdT. Expression of tdT was detected in vivo by means of a Dual Fluorescent Protein Flashlight
(Nightsea, Lexington, MA, USA) and confirmed by PCR genotyping as described [38]. Mice
were humanely killed by CO2 asphyxiation followed by cervical dislocation or decapitation.
Eyes were removed from age- and sex-matched littermates and lenses dissected and imaged as described [35,39,41]. All mouse studies were approved by the Institutional Animal
Care and Use Committee (IACUC) at Washington University (Protocol No. 20190175) in
compliance with the Institute for Laboratory Animal Research (ILAR) guidelines.
2.2. Whole-Mount Imaging of tdT Labeled Lenses
Lenses labeled with membrane-targeted tdT were mounted in agarose-coated petridishes overlaid with pre-warmed cell culture medium and imaged (‘multi-area time-lapse’
function) at various depths (10–400 µm) from the lens surface using a water immersion
objective lens attached to a confocal, fluorescence microscope (FluoView FV1000, Olympus,
Center Valley, PA, USA) as described [35].
2.3. Immunofluorescence Confocal Microscopy
Enucleated eyes were processed using standard formaldehyde-fixed-paraffin-embedded
(FFPE) and frozen section techniques followed by immunolabeling with antigen-specific
primary antibodies (Table S2) and species-appropriate Alexa Fluor 488- or 546-conjugated
secondary antibodies, (Thermo Fisher Scientific, Waltham, MA, USA), counterstaining of
cell nuclei with 40 ,6-diamidino-2-phenylindole (DAPI, MilliporeSigma, Burlington, MA,
USA), and visualization by confocal imaging (FV1000 microscope, Olympus) performed as
described [35,39,41,42].
2.4. Immunoblot and Immunoprecipitation Analyses
Following lens homogenization (Bullet Blender, Next Advance, Troy, NY, USA), lens
post-nuclear lysates were quantified (Non-interfering protein assay, G-Bioscience, St. Louis
MO, USA) and subjected to SDS-PAGE separation (Novex 4–12% gradient gels and an
Invitrogen XCell electrophoresis/blot system, Thermo Fisher Scientific) and immunoblot
analysis (Odyssey Infrared Imaging System, Li-Cor, Lincoln, NE, USA) using appropriate primary antibodies (Table S2) and IRDye labelled secondary antibodies (LiCor) as
described [39,42]. Immunoprecipitation was performed using the Pierce Classic IP Kit
(#26146, Thermo Fisher Scientific) according to the manufacturer’s instructions. Briefly,
lens soluble protein (500 µg) in protease-phosphatase-inhibitor cocktail was precleared (1 h,
4 ◦ C) with Control Agarose Resin and then serially incubated with primary antibody (10 µg,
16 h, 4 ◦ C) followed by Protein A/G Agarose (1 h, 4 ◦ C) to form immune complexes and
the resulting eluted proteins subjected to immunoblot analysis as above with appropriate
primary antibodies (Table S2).
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2.5. RNA Sequencing Analysis
Lens total RNA was prepared in triplicate (6 lenses per sample) using the RNeasy
Kit (Qiagen, Valencia, CA, USA), quantified by spectrophotometry (ND-2000, NanoDrop,
Wilmington, NJ, USA) and then sized for quality by electrophoresis (2100 Bioanalyzer,
Agilent Technologies, Santa Clara, CA, USA) prior to next-generation sequencing in our
Genome Technology Access Center (GTAC). Samples with RNA integrity number (RIN)
values >8.0 were subjected to poly-A selection (oligo-dT), chemical fragmentation, random
hexamer priming, cDNA synthesis, and adapter-ligation using the TruSeq RNA Library
Prep Kit (Illumina, San Diego, CA, USA) followed by paired-end (2 × 101 nt), multiplexed
sequencing (HiSeq 2500, Illumina) according to the manufacturer’s instructions. Raw
data were mapped to the mouse mm10 genome build using STAR (v2.5.3a) [43]. Aligned
reads were filtered for quality using SAMtools (v1.4.1) [44] and read counts per gene were
determined using HTSeq (v0.11.0) [45]. The EdgeR [46] was used to implement the quantileadjusted conditional maximum likelihood method to perform pairwise comparisons and
p-values were adjusted using the Benjamini–Hochberg Procedure. Heatmaps and other
plots were generated using custom scripts and gplots, ggplot2, and ComplexHeatmap [47].
Gene ontology was performed using the Gene Ontology Resource (http://geneontology.org/;
accessed on 28 July 2021) [48].
3. Results
3.1. Epha2-Mutant Mice and Lenses
Using CRISPR/Cas9 gene editing, we generated mice to model a missense variant
(c. 2162G > A, rs116506614) in exon 13 of EPHA2 resulting in a conservative substitution
of arginine-to-glutamine (p.Arg721Gln or p.R721Q) in the TK domain of EPHA2 that has
been associated with age-related cortical cataract in humans [20]. Amino acid alignment
revealed that the R721 codon (CGG) in human EPHA2 was phylogenetically conserved
with the R722 codon (AGG) of mouse Epha2. A donor single-stranded oligonucleotide was
designed to introduce a two base pair change (c.2164_2165delAG > CA) that converted R722
(AGG) to Q722 (CAG). Genomic PCR and Sanger sequencing confirmed the introduction
of the correct A > C transversion and G > A transition in exon-13 of Epha2 in 9 of 47
(19%) founder (F0) mice. However, six of the nine F0 mice had acquired additional ‘offtarget’ sequence changes including insertions and/or deletions (data not shown) leaving
three (6%) correctly targeted mice (one male homozygote and two female heterozygotes)
that were crossed to generate homozygous F1 offspring. Sequencing confirmed germline
transmission of the p.R722Q substitution (Figure 1). Both heterozygous (p.R722Q)
and
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homozygous (p.Q722Q) mutants were viable and fertile with no obvious signs of gross
anatomical or behavioral abnormalities.
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Figure 1. Generation of Epha2-mutant versus Epha2-null mice. (A) Schematic showing the exon organization and protein domains of Epha2 (RefSeq GRCm39, NM_010139.3) located on mouse chromosome 4 (physical location 141028532...141056695)
spanning ~28 kb with 17 coding exons (boxes 1-17). The locations of the p.R722Q variant and the insertion-deletion mutation
(exon-13) in the TK domain relative to the insertion site (exon-5) of the plasmid vector (pMCIneo) used to generate the null
allele are indicated. Protein domains: SP, signal peptide, LBD, ligand-binding domain, FN3-1/2, fibronectin type-III 1 and 2,
TM, transmembrane, TK—tyrosine kinase, SAM—sterile alpha-motif, IPI—PSD95/Dlg/ZO-1 (PDZ) binding motif. (B–F).
Genomic DNA sequence of exon-13 showing the targeted p.R722Q missense variant in heterozygous Epha2-Q722 mice (C)
and homozygous Epha2-Q722 mice (D) and the homozygous near-target insertion-deletion mutation in Epha2-indel722 mice
(F) compared with the corresponding wild-type regions (B,E).

insertion-deletion mutation (exon-13) in the TK domain relative to the insertion site (exon-5) of the plasmid vector (pMCIneo) used to generate the null allele are indicated. Protein domains: SP, signal peptide, LBD, ligand-binding domain,
FN3-1/2, fibronectin type-III 1 and 2, TM, transmembrane, TK—tyrosine kinase, SAM—sterile alpha-motif, IPI—
PSD95/Dlg/ZO-1 (PDZ) binding motif. (B–F). Genomic DNA sequence of exon-13 showing the targeted p.R722Q missense
variant in heterozygous Epha2-Q722 mice (C) and homozygous Epha2-Q722 mice (D) and the homozygous near-target
Cells 2021, 10, 2606
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insertion-deletion mutation in Epha2-indel722 mice (F) compared with the corresponding wild-type regions (B,E).
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3.2. Lens Cell Alignment and Suture Formation in Epha2-Mutant Mice
To visualize the global cellular organization of whole lenses ex vivo from Epha2-mutant
mice, we generated Epha2-mutant and wild type littermates that constitutively express
the red fluorescent protein tdT on cell membranes. First, we focused on the lens equator
region where anterior epithelial cells begin terminal differentiation into highly-elongated
fiber cells that form the refractive mass of the lens. In the wild type tdT lens (postnatal
day 7, P7), equatorial imaging near the surface (10–20 µm depth) revealed the precise
alignment of elongating, hexagonal-shaped fiber cells (in cross section) into meridional
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Figure 3. Whole-mount imaging of epithelial-to-fiber cell alignment in Epha2-mutant lenses. RepreFigure 3. Whole-mount imaging of epithelial-to-fiber cell alignment in Epha2-mutant lenses. Representative superficial (10–20 um depth) equatorial images (A–C), intermediate (100–150 µ m depth)
sentative superficial (10–20 µm depth) equatorial images (A–C), intermediate (100–150 µm depth)
equatorial images (D–F), and deep (300–400 µm depth) equatorial images (G–J) of wild-type
(A,D,G), Epha2-Q722 (B,E,H), and Epha2-indel722 (C,F,I,J) lenses (P7). Scale bar: 50 µm (A–C,G–J),
100 µm (D–F).

We next focused on the anterior and posterior pole regions of the lens where the tips
of elongating fiber cells converge and overlap to form virtual, 3-branch (Y-shaped), suture
lines centered on the optical axis [34,50,51]. In the wild type tdT lens (at P7 and P30), polar
imaging revealed upright Y-shaped anterior suture lines and inverted Y-shaped posterior
suture-lines that were rotationally spaced ~120◦ apart and centered on the optical axis

100 µ m (D–F).
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Figure 4. Whole-mount imaging of Y-suture formation in Epha2-mutant lenses. (A–C,G–I) Representative anterior suture images of wild type (A,G), Epha2-Q722 (B,H), and Epha2-indel722 (C,I) lenses
at P7 (A–C) and P30 (G–I). (D–F,J–L) Representative posterior suture images of wild-type (D,J),
Epha2-Q722 (E,K), and Epha2-indel722 (F,L) lenses at P7 (D–F) and P30 (J–L). Image depth from lens
surface: 100–150 µm (A–L). Scale bar: 100 µm.
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lenses at P7 (A–C) and P30 (G–I). (D–F,J–L) Representative posterior suture images of wild-type
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(D,J), Epha2-Q722 (E,K), and Epha2-indel722 (F,L) lenses at P7 (D–F) and P30 (J–L). Image depth
from lens surface: 100–150 µ m (A–L). Scale bar: 100 µ m.
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diffuse membrane and perinuclear labeling suggesting that at least some of the indel722
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of flattened hexagons, most Epha2-indel722 lens fiber cells exhibited an irregular crosssectional size and shape including 4- or 5-sided cells that were randomly arranged
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Figure 6. Distribution of CDH2, CTNNB1, and GJA3 in Epha2-mutant lenses. Immuno-localization
Figure 6. Distribution of CDH2, CTNNB1, and GJA3 in Epha2-mutant lenses. Immuno-localization
of CDH2 (A–C), CTNNB1 (D–I), and GJA3 (G–I) in wild type (A,D,G), Epha2-Q722 mutant (B,E,H)
of CDH2 (A–C), CTNNB1 (D–I), and GJA3 (G–I) in wild type (A,D,G), Epha2-Q722 mutant (B,E,H)
and Epha2-indel722 mutant (C,F,I) lenses (P28). Scale bar, 20 µ m.
and Epha2-indel722 mutant (C,F,I) lenses (P28). Scale bar, 20 µm.
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only trace complex formation with CTNNB1 relative to that between CTNNB1 and CDH2
(Figure 7A,B). By contrast, EPHA2 formed strong complexes with Src kinase (Figure 7C).
Since the Q722 and indel722 mutations were located within the tyrosine-kinase domain
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Figure 7. EPHA2 complex formation and phosphorylation status in the lens. (A–C) ImmunoprecipFigure 7. EPHA2 complex formation and phosphorylation status in the lens. (A–C) Immunoitation analysis of wild type lenses (P21) showing that EPHA2 forms trace complexes with CTNNB1
precipitation analysis of wild type lenses (P21) showing that EPHA2 forms trace complexes with
but not with CDH2 (A) and that CTNNB1 complexes strongly with CDH2 but not with EPHA2 (B),
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wild-type (Figure 8). RNA-seq data showed high consistency between biological tripli-
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Omnibus (GEO) database under accession no. GSE181358. Biological triplicate samples
were sequenced to a depth of >20 M reads and aligned to the mouse mm10 genome build
with >98% alignment rate. Differential expression analysis using EdgeR (fold-change, FC
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Figure 8. Gene expression changes in Epha2-mutant and Epha2-null lenses (P7). RNA-seq analysis
identifies unique expression changes in Epha2-mutant (Q722, indel722) and Epha2-null lenses compared to wild type (A). Genes known to be involved in lens cell differentiation, Lgsn and Clic5, show
varied downregulation across Epha2 genotypes (B).

4. Discussion
In this study, we have demonstrated that mice homozygous for mutations (Q722 or
indel722) in the tyrosine kinase domain of EPHA2 underwent variable changes in lens
cell organization and gene expression. Epha2-Q722 mice displayed clear lenses with mild
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defects in Y-suture branching at the posterior pole, whereas Epha2-indel722 mice presented
clear lenses with translucent regions resulting from severe disturbance of (1) epithelial-tofiber cell alignment (meridional row and fulcrum formation) at the lens equator, (2) radial
cell column formation throughout the lens cortex, and (3) Y-suture branching at the lens
poles—similar to those described for Epha2-null lenses [35]. As meridional row and fulcrum
formation were already disturbed at P7, it is conceivable that cell patterning defects may
have arisen during earlier stages of lens development. EPHA2 was mainly localized to
radial columns of hexagonal fiber cell membranes throughout the cortex of Epha2-Q722
lenses, whereas fiber cell columns were severely disorganized in Epha2-indel722 lenses
along with cytoplasmic retention of EPHA2—consistent with failed targeting to the cell
surface. EPHA2 formed strong immuno-complexes with Src kinase in vitro supporting a
role for EPHA2/Src signaling during lens development [32]. However, we were unable to
replicate strong EPHA2 complexes with CTNNB1 or CDH2 in the lens at wean-age (P21)
similar to those reported in transfected (293T) cells and in the lens at an earlier stage of
postnatal development (P10) [52,53]. EPHA2 was abundantly phosphorylated on serine897/898 in wild type and Epha2-Q722 mutant lenses (P21), whereas EPHA2 tyrosine588/589
phosphorylation was not detected using similar immunoblot analysis of whole lenses. The
relative abundance of serine-897/898 phosphorylation in the lens suggests that ephrinindependent or non-canonical EPHA2 signaling [57] may participate in lens cell migration.
However, we cannot exclude a role for ephrin-dependent or canonical EPHA2 signaling
since the hallmark tyrosine-588/589 phosphorylation may be restricted to specific subregions of the lens (e.g., specific lens epithelial cells) requiring more detailed studies. At the
transcript level, several genes encoding cytoskeletal-associated proteins were differentially
regulated including shared downregulation of Lgsn in both Epha2-mutant and Epha2-null
lenses and Clic5 in Epha2-indel722 and Epha2-null lenses. Combined, our imaging and
transcript data support a role for EPHA2 signaling—potentially via the cytoskeleton—in
generating the precise cellular patterning underlying the refractive properties and optical
quality of the crystalline lens.
Functional (over)expression studies in cultured (transfected) cell-lines have been used
to predict diverse pathogenic mechanisms underlying EPHA2-related forms of human
cataract. A non-coding risk allele for age-related cataract (rs6603883) located in a pairedbox-2 (PAX2) binding-site within the EPHA2 gene promoter suggested that it acts by
down-regulating EPHA2 expression in cultured lens cells [58]. Several SAM domain
mutations underlying early-onset cataract were reported to alter receptor stability, function
and/or sub-cellular distribution [59–61]. Of three missense variants located within the
TK domain of EPHA2 (amino acid residues 613–871), two (p.G668D, p.Q669H) have
been associated with early-onset cataract and one (p.R721Q) with age-related cortical
cataract in humans [20,62,63]. The p.G668D mutant has been associated with increased
proteasome-mediated degradation, altered subcellular localization, and increased cell
migration [63], whereas the p.R721Q mutant was associated with increased basal kinase
activation in the absence of ligand, inhibition of clonal cell growth, and variable intracellular
retention [20]. In our mouse model of the human EPHA2-p.R721Q variant (Epha2-Q722),
homozygous expression of the equivalent variant protein at constitutive levels resulted in
mild disturbance of the posterior Y-sutures but not in early-onset or age-related cataract
(Figures 2 and 4). Similarly, homozygous expression of an in-frame TK domain mutant
did not elicit cataract development in Epha2-indel722 lenses despite decreased levels
and cytoplasmic retention of the mutant protein coupled with severe disorganization
of lens fiber cells causing translucent regions of poor optical quality (Figure 2). While
there was some mechanistic agreement between in vitro (overexpression) and in vivo
(constitutive) expression studies of EPHA2 mutants (e.g., intracellular retention and altered
cell growth/migration), we cannot account specifically for the lack of cataract penetrance
in the Epha2-mutant mice reported here. Contributing factors include species differences in
genetic background modifier effects, variable environmental risk factors (e.g., UV exposure
in nocturnal mice versus diurnal humans), and morphological differences between the
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relatively small, almost spherical mouse lens with Y-suture branching versus the much
larger, ellipsoidal human lens with more complex star-suture branching [51].
While we did not observe cataract formation in Epha2-mutant (Q722, indel722) or
Epha2-null lenses [35], there were significant changes in lens gene expression at the transcript level between Epha2 genotypes as early as P7. Among the most upregulated genes
(>4-fold) in both Epha2-Q722 and Epha2-indel722 mutant lenses were those for tubulin
alpha 1C (TUBA1C) and alkaline ceramidase-2 (ACER2). TUBA1C serves as a prognostic
biomarker for a variety of cancers [64] and ACER2 is a Golgi enzyme involved in regulating
B1 integrin maturation and cell adhesion [65]. In Epha2-Q722 and Epha2-null lenses, the
gene for steroidogenic acute regulatory protein-related lipid transfer (START) domaincontaining protein 9 (STARD9) was strongly upregulated, whereas that for doublecortin
domain-containing 2a (DCDC2a) was strongly upregulated in Epha2-indel722 and Epha2null lenses. STARD9 functions as a centrosomal protein that regulates both interphase
and mitotic spindle microtubules [66], whereas DCDC2a serves as a micro-tubule associated protein localized to hair cell kinocilia and supporting cell primary cilia that when
mutated causes non-syndromic recessive deafness in humans [67]. The most consistently
upregulated gene in both Epha2-mutant and Epha2-null lenses was that for WD-repeat and
FYVE-domain-containing protein-1 (WDFY1), which serves as an adapter protein in tolllike receptor signaling [68]. Finally, the gene for dorsal inhibitory axon guidance protein
(DRAXIN) was strongly upregulated in Epha2-indel722 lenses and that for actin, alpha 2,
smooth muscle, aorta (ACTA2) was moderately upregulated in Epha2-null lenses. While
ACTA2 serves as a marker for epithelial–mesenchymal transition during cataract formation [69] and several of the other upregulated genes share cytoskeletal-related or signaling
functions, none have yet been associated with EPHA2 signaling or lens cell differentiation.
Among the most downregulated genes, two have been directly implicated in lensspecific cytoskeleton biology. The most consistently downregulated gene in Epha2-Q722
(>−4-fold), Epha2-indel722 (>−100-fold), and Epha2-null (>−3-fold) lenses was that for
lens glutamine synthase-like or lengsin (LGSN), also known as glutamate-ammonia ligase
(glutamine synthase) domain containing 1 (GLULD1), a lens-specific protein with a glutamine synthase domain lacking glutamine synthase activity [55]. LGSN is a late marker
for lens fiber cell terminal differentiation and has been shown to co-localize with actin and
interact with the lens-specific intermediate filament protein, beaded filament structural
protein-2 (BFSP2), also known as cytoskeletal protein 49 (CP49) or phakinin, suggesting
that LGSN represents a recruited enzyme adapted to act as a cytoskeletal component or
chaperone during remodeling of the lens cytoskeleton [55,70].
The most downregulated gene in Epha2-indel722 mutant lenses (<−1000-fold), and to
a lesser extent in Epha2-null lenses (<−2-fold), was that for chloride intracellular channel 5
(CLIC5). Mutations in the human CLIC5 gene have been linked with progressive autosomal
recessive, non-syndromic sensorineural hearing impairment with or without vestibular
dysfunction and CLIC5 was found to be abundantly expressed in the fetal inner ear [71,72].
Similarly, in jitterbug (jbg) mice a spontaneous deletion mutation in Clic5 underlies hearing
loss with vestibular and renal dysfunction and CLIC5 was localized to the base of hair
cell stereocilia where it complexes with radixin, taperin, and myosin VI to stabilize cell
membrane–actin cytoskeleton attachments [73]. Recently, CLIC5 been localized to cilia
and/or centrosomes in the lens and Clic5-mutant (jtb) lenses were found to exhibit defective
suture formation [56]. Further, EPHA2 has been shown to regulate Src/cortactin/F-actin
complexes during epithelial-to-fiber cell morphogenesis (meridional row and fulcrum
formation) at the lens equator [32]. Collectively, these observations point to a functional
synergy between EPHA2 and several cytoskeletal proteins with LGSN and CLIC5 providing
promising candidates for future studies of EPHA2 signaling in the lens.
In conclusion, our data suggest that EPHA2 signaling is required for lens cell pattern recognition and support a role for EPHA2 in cytoskeleton dynamics during lens
cell differentiation.
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Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/cells10102606/s1. Figure S1. Allele-specific PCR-genotyping of Epha2-mutant mice. (A) PCR
amplicons of wild type (R722), heterozygous Epha2-Q722 (R722Q) and homozygous Epha2-Q722
(Q722) alleles using three exon-13 primers (Table S1) indicated by arrows in the schematic below.
(B) PCR amplicons of wild type (+/+), heterozygous Epha2-indel722 (+/indel722), and homozygous
Epha2-indel722 (indel722) alleles using exon-13 flanking primers. Figure S2. RNA-seq data differential
expression analysis. Triplicate samples from wild-type (WT), Epha2-mutant (Q722, indel722), and
Epha2-null lenses (P7) mostly cluster independently for all dysregulated genes (A). Full heat-map of
Figure 8A displays FC of each gene relative to WT in each Epha2 genotype tested (B). Figure S3. Gene
ontogeny (GO) analysis of the combined upregulated genes from Epha2-mutant (Q722, indel722) and
Epha2-null lenses (P7). Table S1. Primer sequences used for PCR-amplification and Sanger sequencing
of Epha2. Table S2. Primary antibodies used for confocal microscopy, immunoprecipitation, and
immunoblotting. Table S3. Differentially regulated genes (fold-change FC ≥ 2, false discovery rate
FDR ≤ 0.05) in the Epha2-Q722 lens (P7). Table S4. Differentially regulated genes (fold-change FC ≥ 2,
false discovery rate FDR ≤ 0.05) in the Epha2-indel722 lens (P7). Table S5. Differentially regulated
genes (fold-change FC ≥ 2, false discovery rate FDR ≤ 0.05) in the Epha2-null lens (P7).
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